X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Lupin Ltd with JUBILANT LIFE SCIENCES - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

LUPIN LTD vs JUBILANT LIFE SCIENCES - Comparison Results

LUPIN LTD    Change

Lupin is a leading pharmaceutical company with a strong presence in anti-infective, cardiovascular and asthma. Apart from having a strong domestic presence, the company markets its products in the regulated markets of the US and Europe and semi-regul... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    LUPIN LTD JUBILANT LIFE SCIENCES LUPIN LTD/
JUBILANT LIFE SCIENCES
 
P/E (TTM) x 19.8 29.2 67.7% View Chart
P/BV x 2.7 6.0 44.7% View Chart
Dividend Yield % 0.9 0.3 308.2%  

Financials

 LUPIN LTD   JUBILANT LIFE SCIENCES
EQUITY SHARE DATA
    LUPIN LTD
Mar-17
JUBILANT LIFE SCIENCES
Mar-14
LUPIN LTD/
JUBILANT LIFE SCIENCES
5-Yr Chart
Click to enlarge
High Rs1,750187 936.8%   
Low Rs1,38465 2,125.2%   
Sales per share (Unadj.) Rs387.4364.3 106.3%  
Earnings per share (Unadj.) Rs56.66.8 827.3%  
Cash flow per share (Unadj.) Rs76.824.5 313.6%  
Dividends per share (Unadj.) Rs7.503.00 250.0%  
Dividend yield (eoy) %0.52.4 20.1%  
Book value per share (Unadj.) Rs298.9164.9 181.3%  
Shares outstanding (eoy) m451.58159.28 283.5%   
Bonus/Rights/Conversions ESOPS--  
Price / Sales ratio x4.00.3 1,169.9%   
Avg P/E ratio x27.718.4 150.4%  
P/CF ratio (eoy) x20.45.1 396.6%  
Price / Book Value ratio x5.20.8 686.3%  
Dividend payout %13.243.8 30.2%   
Avg Mkt Cap Rs m707,51320,061 3,526.8%   
No. of employees `00016.86.2 271.5%   
Total wages/salary Rs m28,49511,052 257.8%   
Avg. sales/employee Rs Th10,418.39,383.0 111.0%   
Avg. wages/employee Rs Th1,697.01,786.9 95.0%   
Avg. net profit/employee Rs Th1,523.0176.3 863.9%   
INCOME DATA
Net Sales Rs m174,94358,034 301.5%  
Other income Rs m1,065191 558.8%   
Total revenues Rs m176,00858,224 302.3%   
Gross profit Rs m44,9315,786 776.5%  
Depreciation Rs m9,1222,812 324.4%   
Interest Rs m1,5253,237 47.1%   
Profit before tax Rs m35,349-72 -49,027.6%   
Minority Interest Rs m-72-286 25.1%   
Prior Period Items Rs m830-   
Extraordinary Inc (Exp) Rs m02,145 0.0%   
Tax Rs m9,785696 1,405.1%   
Profit after tax Rs m25,5751,090 2,345.4%  
Gross profit margin %25.710.0 257.6%  
Effective tax rate %27.7-965.9 -2.9%   
Net profit margin %14.61.9 778.0%  
BALANCE SHEET DATA
Current assets Rs m119,54229,280 408.3%   
Current liabilities Rs m61,20638,912 157.3%   
Net working cap to sales %33.3-16.6 -200.9%  
Current ratio x2.00.8 259.6%  
Inventory Days Days7684 90.1%  
Debtors Days Days9051 177.3%  
Net fixed assets Rs m131,66055,712 236.3%   
Share capital Rs m903155 584.6%   
"Free" reserves Rs m134,07320,968 639.4%   
Net worth Rs m134,97626,265 513.9%   
Long term debt Rs m56,47817,169 329.0%   
Total assets Rs m266,07388,606 300.3%  
Interest coverage x24.21.0 2,472.6%   
Debt to equity ratio x0.40.7 64.0%  
Sales to assets ratio x0.70.7 100.4%   
Return on assets %10.24.9 208.5%  
Return on equity %18.94.2 456.4%  
Return on capital %19.311.6 166.6%  
Exports to sales %037.8 0.0%   
Imports to sales %016.5 0.0%   
Exports (fob) Rs mNA21,933 0.0%   
Imports (cif) Rs mNA9,567 0.0%   
Fx inflow Rs m81,88522,004 372.1%   
Fx outflow Rs m21,50611,749 183.0%   
Net fx Rs m60,37810,255 588.8%   
CASH FLOW
From Operations Rs m41,1488,026 512.7%  
From Investments Rs m-25,287-1,744 1,449.8%  
From Financial Activity Rs m4,332-4,447 -97.4%  
Net Cashflow Rs m20,1931,834 1,100.7%  

Share Holding

Indian Promoters % 46.6 45.6 102.2%  
Foreign collaborators % 0.2 3.5 5.7%  
Indian inst/Mut Fund % 11.3 8.7 129.9%  
FIIs % 31.9 21.2 150.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 10.1 21.1 47.9%  
Shareholders   98,259 23,815 412.6%  
Pledged promoter(s) holding % 0.0 15.9 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare LUPIN LTD With:   SHASUN PHARMA  WYETH LTD  ABBOTT INDIA  ALEMBIC LTD  GSK PHARMA  

Compare LUPIN LTD With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades in Red; PSU & Energy Stocks Decline(01:30 pm)

Indian share markets continued to trade in red during the noon session weak Asian markets. PSU stocks and energy stocks are witnessing majority of the selling activity.

Related Views on News

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Lupin: US Markets Drags down Revenues and Net Profits (Quarterly Results Update - Detailed)

Nov 2, 2017

Domestic markets registers robust growth in the quarter

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

More Views on News

Most Popular

The Foundation for Sensex 100,000 is Laid(The 5 Minute Wrapup)

Feb 17, 2018

Top three reasons for Tanushree's presentation at Equitymaster Conference to be centered around a possible 30% correction.

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

The Markets Want Your Money. Don't Give It to Them.(Smart Contrarian)

Feb 9, 2018

MFs are having a gala time taking money from over-eager investors and funneling it into equities. Smart investors, though, know better than to do that.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

NPAs Set to Rise Further with New RBI Rules(Chart Of The Day)

Feb 15, 2018

The RBI overhauls bad loan framework. Banks may come under additional pressure due to rising NPAs and increased provisioning.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

LUPIN LTD SHARE PRICE


Feb 22, 2018 03:37 PM

TRACK LUPIN LTD

  • Track your investment in LUPIN LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

LUPIN LTD 8-QTR ANALYSIS

COMPARE LUPIN LTD WITH

MARKET STATS